$VHC
VirnetX Holding Corp

2023 Q3 Form 10-Q Financial Statement

#000114036123039281 Filed on August 11, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $3.000K $2.000K $34.00K
YoY Change -25.0% -94.12% 126.67%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change
Gross Profit $0.00 $2.000K $34.00K
YoY Change -100.0% -94.12% 126.67%
Gross Profit Margin 0.0% 100.0% 100.0%
Selling, General & Admin $4.420M $7.366M $3.046M
YoY Change 6.69% 141.83% 1.26%
% of Gross Profit 368300.0% 8958.82%
Research & Development $1.218M $4.755M $1.255M
YoY Change 0.16% 278.88% 9.23%
% of Gross Profit 237750.0% 3691.18%
Depreciation & Amortization $0.00 $2.000K $1.000K
YoY Change -100.0% 100.0% -50.0%
% of Gross Profit 100.0% 2.94%
Operating Expenses $5.638M $12.12M $4.301M
YoY Change 5.21% 181.82% 3.46%
Operating Profit -$5.635M -$12.12M -$4.267M
YoY Change 5.23% 184.02% 3.02%
Interest Expense $720.0K $740.0K $203.0K
YoY Change 22.24% 264.53% 1930.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.919M -$11.38M -$4.064M
YoY Change 3.21% 180.0% -1.65%
Income Tax -$1.000K $0.00 $373.0K
% Of Pretax Income
Net Earnings -$4.918M -$11.38M -$4.437M
YoY Change 14.91% 156.46% 25.94%
Net Earnings / Revenue -163933.33% -568950.0% -13050.0%
Basic Earnings Per Share -$1.36 -$0.16 -$0.06
Diluted Earnings Per Share -$1.36 -$0.16 -$62.27K
COMMON SHARES
Basic Shares Outstanding 71.64M 71.42M 71.23M
Diluted Shares Outstanding 3.612M 71.47M 71.26M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $61.03M $66.23M $161.7M
YoY Change -61.62% -59.03% -7.91%
Cash & Equivalents $27.85M $25.97M $127.2M
Short-Term Investments $33.18M $40.26M $34.48M
Other Short-Term Assets $400.0K $480.0K $514.0K
YoY Change 8.11% -6.61% -84.68%
Inventory
Prepaid Expenses
Receivables $2.000K $4.000K $19.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $61.47M $66.71M $162.2M
YoY Change -61.43% -58.87% -9.34%
LONG-TERM ASSETS
Property, Plant & Equipment $6.000K $8.000K $15.00K
YoY Change -53.85% -46.67% 66.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.000M
YoY Change
Other Assets $0.00 $19.00K $17.51M
YoY Change -100.0% -99.89% -2.59%
Total Long-Term Assets $2.444M $534.0K $17.53M
YoY Change -86.37% -96.95% -2.55%
TOTAL ASSETS
Total Short-Term Assets $61.47M $66.71M $162.2M
Total Long-Term Assets $2.444M $534.0K $17.53M
Total Assets $63.91M $67.25M $179.7M
YoY Change -63.96% -62.58% -8.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.200M $397.0K $350.0K
YoY Change -18.75% 13.43% -21.35%
Accrued Expenses $400.0K $392.0K $333.0K
YoY Change 8.99% 17.72% 8.82%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.601M $813.0K $738.0K
YoY Change -15.74% 10.16% -4.03%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00 $18.00K
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $0.00 $0.00 $18.00K
YoY Change -100.0% -100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.601M $813.0K $738.0K
Total Long-Term Liabilities $0.00 $0.00 $18.00K
Total Liabilities $1.601M $813.0K $756.0K
YoY Change -15.91% 7.54% -1.69%
SHAREHOLDERS EQUITY
Retained Earnings -$179.4M -$174.5M
YoY Change 184.87%
Common Stock $0.00 $7.000K
YoY Change -100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $62.31M $66.43M $179.0M
YoY Change
Total Liabilities & Shareholders Equity $63.91M $67.25M $179.7M
YoY Change -63.96% -62.58% -8.72%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$4.918M -$11.38M -$4.437M
YoY Change 14.91% 156.46% 25.94%
Depreciation, Depletion And Amortization $0.00 $2.000K $1.000K
YoY Change -100.0% 100.0% -50.0%
Cash From Operating Activities -$3.300M -$11.75M -$3.334M
YoY Change 31.42% 252.58% -91.93%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.200M $12.11M -$5.867M
YoY Change -127.57% -306.39% 184.67%
Cash From Investing Activities $5.200M $12.11M -$5.867M
YoY Change -127.57% -306.39% 184.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -71.43M -29.00K
YoY Change 246224.14% -85.2%
NET CHANGE
Cash From Operating Activities -3.300M -11.75M -3.334M
Cash From Investing Activities 5.200M 12.11M -5.867M
Cash From Financing Activities 0.000 -71.43M -29.00K
Net Change In Cash 1.900M -71.08M -9.230M
YoY Change -108.89% 670.1% -78.82%
FREE CASH FLOW
Cash From Operating Activities -$3.300M -$11.75M -$3.334M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
182733000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
152244000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
185449000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
66434000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
178966000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
77136000
vhc Concentration Risk Number Of Financial Institutions
ConcentrationRiskNumberOfFinancialInstitutions
2
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2023Q2 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
66415000
CY2023Q2 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
66229000
CY2022Q4 vhc Cash And Available For Sale Securities Amortized Cost Basis
CashAndAvailableForSaleSecuritiesAmortizedCostBasis
152400000
CY2022Q4 vhc Cash And Available For Sale Securities Fair Value Disclosure
CashAndAvailableForSaleSecuritiesFairValueDisclosure
152023000
CY2023Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued
0
CY2023Q2 us-gaap Unrecognized Tax Benefits Interest On Income Taxes Accrued
UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued
0
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
0
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
0
CY2023Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001082324
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
66434000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
178966000
CY2023Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11379000
CY2023Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-78000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15924000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0049
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
373000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4064000
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0918
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-684000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8441000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.081
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
3500000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
5253971
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-11379000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-4437000
us-gaap Net Income Loss
NetIncomeLoss
-15846000
us-gaap Net Income Loss
NetIncomeLoss
-7757000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71466000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71255000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71445000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
71244000
CY2023Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71466000
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71255000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71445000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
71244000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.06
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.06
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6974580
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6974580
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7520546
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7520546

Files In Submission

Name View Source Status
0001140361-23-039281-index-headers.html Edgar Link pending
0001140361-23-039281-index.html Edgar Link pending
0001140361-23-039281.txt Edgar Link pending
0001140361-23-039281-xbrl.zip Edgar Link pending
brhc20056791_10q.htm Edgar Link pending
brhc20056791_ex10-2.htm Edgar Link pending
brhc20056791_ex31-1.htm Edgar Link pending
brhc20056791_ex31-2.htm Edgar Link pending
brhc20056791_ex32-1.htm Edgar Link pending
brhc20056791_ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logo_virtnetcx.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
brhc20056791_10q_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vhc-20230630.xsd Edgar Link pending
vhc-20230630_def.xml Edgar Link unprocessable
vhc-20230630_lab.xml Edgar Link unprocessable
vhc-20230630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
vhc-20230630_cal.xml Edgar Link unprocessable